Nature4mon
Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer
Recently developed major histocompatibility complex (MHC) multimer technologies allow visualization and isolation of antigen-specific T cells. However, functional analysis and in vivo transfer of ...
Fate Therapeutics Presents Pan-tumor Targeting Preclinical Data for FT836 MICA/B-targeted CAR T-cell Product Candidate at 2024 SITC Annual Meeting
Multiplexed-engineered, iPSC-derived CAR T Cell Targets Proteins Expressed on Cancer Cells in Response to Cellular Stress and ...
Medscape1mon
Immune Recognition and Rejection of Allogeneic Skin Grafts
The high determinant density model, in which the structure of the allogeneic MHC molecule governs T-cell recognition; [34] The multiple binary complex model, in which alloantigen recognition is ...
PipelineReview.com8d
Theragent and CellVax Therapeutics Announce First Patient Dosed in Phase 2 Trial of FK-PC101, a Novel Personalized Cancer Immunotherapy
ARCADIA, CA, USA I 11, 2024 I Theragent Inc., a comprehensive CDMO focused on advancing next-generation cell-based therapies, has announced a ...